Lawrence Gozlan

Lawrence Gozlan

Chairman at ENLITIC, INC.

Net worth: 39 161 $ as of 2026-09-29

47 year
Health Technology
Technology Services
Finance

Profile

Mr. Lawrence B. Gozlan is an Independent Non-Executive Director at Ceryvyn Therapeutics Ltd., a Chairman at Enlitic, Inc., a Manager-Life Sciences Investment at Jagen Pty Ltd. and a Chief Investment Officer at Scientia Capital Pty Ltd. He is on the Board of Directors at Ceryvyn Therapeutics Ltd., AusBiotech Ltd., Alterity Therapeutics Ltd. and Faraday Pharmaceuticals, Inc. (Washington).
Mr. Gozlan was previously employed as a Chairman by Phosphagenics Ltd., an Independent Non-Executive Director by OncoSil Medical Ltd., a Non-Executive Director by Telesso Technologies Ltd., a Non-Executive Director by Nohla Therapeutics, Inc., and a Non-Executive Director by Novita Healthcare Ltd. He received his undergraduate degree from the University of Melbourne.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-20 90,910 ( 0.04% ) 25 457 $ 2026-09-29
2025-12-18 1,877,357 ( 0.14% ) 13 705 $ 2026-09-29

Lawrence Gozlan active positions

CompaniesPositionStart
ALTERITY THERAPEUTICS LIMITED Director/Board Member 2011-08-07
CERYVYN THERAPEUTICS LIMITED Director/Board Member 2020-07-23
ENLITIC, INC. Chairman -
Chief Executive Officer -
Director/Board Member 2013-01-31
Director/Board Member -
Corporate Officer/Principal 2006-12-31

Former positions of Lawrence Gozlan

CompaniesPositionEnd
AVECHO BIOTECHNOLOGY LIMITED Chairman 2015-05-11
ONCOSIL MEDICAL LIMITED Director/Board Member 2015-05-03
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Lawrence Gozlan's experience

Education of Lawrence Gozlan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Finance

Commercial Services

Finance

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Lawrence Gozlan